Form 4: Apyx Medical Corp Director Wendy Levine Reports Stock Option Grant

Director Wendy Levine of Apyx Medical Corp reports the grant of a stock option.

Summary

• Wendy Levine, a director of Apyx Medical Corp, filed a Form 4.
• The form reports the grant of a stock option to purchase 64,000 shares of Apyx Medical Corp common stock.
• The option was granted on May 15, 2025, with an exercise price of $1.48.
• The options vest ratably over 12 months and are fully vested on the first anniversary of the grant date, expiring on May 15, 2035.
• Following the transaction, Levine directly owns 64,000 derivative securities.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock option grant, which is generally neutral. It suggests confidence in the company's future, but doesn't provide strong positive or negative signals.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders, incentivizing them to work towards increasing the company's value.

Industry Context

Stock option grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in growth-oriented sectors like medical technology.
• The vesting schedule of 12 months is fairly typical.
• The size of the grant (64,000 shares) would need to be compared to grants made to directors at comparable companies to assess its relative significance.

Stakeholder Impact

• The stock option grant could potentially incentivize the director to make decisions that benefit shareholders in the long term.

Key Dates

Keywords

Form 4, stock option, beneficial ownership, Apyx Medical Corp, Wendy Levine, director